COMMUNIQUÉS West-GlobeNewswire

Better Choice Company Announces Closing of the SRx Health Merger, Name/Symbol Change and Completes $8.8 Million Private Placement Priced Above Last Market Closing Price

25/04/2025 - 14:45

TAMPA, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced the closing of its business [...]

Better Choice Company Cancels Previously Announced Stock Dividend

25/04/2025 - 14:45

TAMPA, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that it is canceling the [...]

Best Testosterone Booster For Erectile Dysfunction (ED) And Muscle Building 2025: Top T Booster Supplement For Men Over 40 And 50 – By Testo Prime

25/04/2025 - 14:52

Clinically Tested Best Testosterone Booster Supplement for Men Over 40 and 50 Combines Evidence-Based Natural Ingredients Like FENUGREEK, KSM-66 Ashwagandha, VITAMIN D, D-Aspartic Acid, and Panax Ginseng to Support [...]

Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)

25/04/2025 - 15:00

Leiden, the Netherlands, April 25, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the following presentations by the Company or its collaborators at the 2025 [...]

ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints

25/04/2025 - 15:00

In ASPEN-03 and ASPEN-04 trials, efficacy data do not support advancing evorpacept in combination with Merck’s anti-PD-1 therapy, KEYTRUDA ® (pembrolizumab), into a registrational study Company remains confident in [...]

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

25/04/2025 - 15:00

DALLAS, TX, April 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals Inc. (NASDAQ: MGRX) (“ Mangoceuticals ” or “ MGRX ”), a company focused on developing, marketing, and selling a variety of health and wellness products via a [...]

Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 30, 2025

25/04/2025 - 15:00

Hamilton, Bermuda, April 25, 2025 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB: CYTOF), a company dedicated to developing and commercializing RNA delivery technology for targets [...]

InspireMD to Announce First Quarter 2025 Financial Results

25/04/2025 - 15:00

MIAMI, April 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced [...]

Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025

25/04/2025 - 15:00

BEDFORD, Mass., April 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its first quarter [...]

A Place to Heal: Virtue Recovery Center Stands with Veterans and Families Across the United States

25/04/2025 - 12:00

LAS VEGAS, April 25, 2025 (GLOBE NEWSWIRE) -- When military service ends, many Veterans find themselves facing a new kind of battle — one marked by PTSD, addiction, and the struggle to reconnect with daily life. With an [...]

Philips provides update on the Annual General Meeting of Shareholders 2025 Agenda

25/04/2025 - 12:00

April 25, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) provides an update on the Annual General Meeting 2025 which has been convened on March 24, 2025 (AGM). As previously announced, the AGM [...]

CPOINT Capital Corp. Announces Changes to Holdings in Conavi Medical Corp.

25/04/2025 - 13:00

TORONTO, April 25, 2025 (GLOBE NEWSWIRE) -- CPOINT Capital Corp. (“ CPOINT ”) announces that, on April 23, 2025, it and its affiliate Juno Pharmaceuticals LP (“ Juno ”) acquired 1,875,000 common shares (the “ Common [...]

BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference

25/04/2025 - 13:00

Advanced Spatial Quinomics Study Reveals Novel Insights into the Therapeutic Impact of BPM31510, Being Studied as a Potential Treatment for Primary CoQ10 Deficiency and Other Mitochondrial Diseases BOSTON, April 25, [...]

Okita Nail Fungus Light Under Review: Best At-Home Toenail Fungus Cleaning Light for Onychomycosis

25/04/2025 - 07:20

Discover How the Okita Nail Fungus Light Uses Red & Blue LED Therapy to Help Improve Nail Clarity at Home—A Drug-Free, Pain-Free Solution for Onychomycosis Sufferers Seeking Visible Results Wanchai, Hong Kong, April [...]

SYNC Sunlight Loophole Under Review: Unique Metabolism Boosting Formula to Burn Belly Fat Fast

25/04/2025 - 07:23

Disrupting the Weight Loss Plateau: New Clock Gene Supplement ‘SYNC’ Restores Metabolic Rhythm for Natural Fat-Burning & All-Day Energy Aurora, Colorado, April 25, 2025 (GLOBE NEWSWIRE) -- If you've ever felt like [...]

Vistin Pharma ASA: First quarter 2025 financial results

25/04/2025 - 07:35

Oslo, Norway, 25 th of April 2025 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2025. Revenue in the first quarter ended at MNOK 115 compared to MNOK 104 in Q1 2024. Sales [...]

Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease

25/04/2025 - 08:00

ORION CORPORATION PRESS RELEASE 25 APRIL 2025 at 9.00 EEST Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease Orion Corporation (“ [...]

TREMFYA® (guselkumab) receives European Commission approval for adults with moderately to severely active ulcerative colitis, strengthening Johnson & Johnson’s leadership in inflammatory bowel disease

25/04/2025 - 09:00

The first a approved fully-human, dual-acting interleukin-23 (IL-23) inhibitor in moderately to severely active ulcerative colitis, 1 , 2 , 3 , 4 , 5 guselkumab showed statistically higher rates of endoscopic [...]

Best Thermogenic Fat Burner Supplements 2025: Top Fat Burning Pills for Weight Loss From PhenQ

25/04/2025 - 09:23

Clinically-backed thermogenic fat burners accelerate metabolism, ignite fat loss, and curb appetite—PhenQ leads 2025’s top fat-burning supplements for men and women aiming for sustainable weight loss results. NEW YORK, [...]